cbdMD (YCBD) Total Current Liabilities (2016 - 2025)
cbdMD's (YCBD) quarterly Total Current Liabilities came in at $2.8 million in Q4 2025, down 69.75% year-on-year from $9.2 million in Q4 2024, and down 13.14% quarter-over-quarter from $3.2 million in Q3 2025.
cbdMD (YCBD) Total Current Liabilities (2016 - 2025) Analysis & Trends
cbdMD has disclosed Total Current Liabilities across 10 years of filings, most recently posting $2.8 million for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $2.8 million, down 69.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (down 69.75% YoY), and the FY2025 annual result was $3.2 million, down 62.94% from the prior year.
- Total Current Liabilities came in at $2.8 million for Q4 2025 at cbdMD, down from $3.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $9.9 million in Q1 2025 to a low of $2.8 million in Q4 2025.
- The 5-year median for Total Current Liabilities is $5.9 million (2022), against an average of $6.1 million.
- Across the five-year window, Total Current Liabilities surged 84.53% in 2024 and slumped 69.75% in 2025, its largest moves.
- cbdMD's Total Current Liabilities stood at $6.8 million in 2021, then decreased by 17.87% to $5.6 million in 2022, then climbed by 7.55% to $6.0 million in 2023, then jumped by 53.55% to $9.2 million in 2024, then plunged by 69.75% to $2.8 million in 2025.
- The last three Total Current Liabilities figures came in at $2.8 million (Q4 2025), $3.2 million (Q3 2025), and $3.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn | 2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.77 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 6.94 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 4.67 Mn |
| Jun 30, 2023 | 4.38 Mn |
| Mar 31, 2023 | 4.68 Mn |
| Dec 31, 2022 | 5.55 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 5.73 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | 6.76 Mn |
| Sep 30, 2021 | 6.92 Mn |
| Jun 30, 2021 | 6.75 Mn |
| Mar 31, 2021 | 6.86 Mn |